The Pharma Letter5h
Akribion Therapeutics secures $9 million seed funding
German biotech Akribion Therapeutics has emerged from stealth with 8 million euros ($9 million) in seed funding to accelerate ...
Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion
Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
Le Lézard10h
Akribion Therapeutics exits from stealth with ?8m seed financing to pioneer RNA-guided, programmable cell depletion
Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
Fucking Young!11h
MR PORTER Pre-Spring 2025 Campaign
MR PORTER’s Pre-Spring 2025 campaign offers a fresh perspective on classic styles and new trends, designed to update and ...
Investing10h
Infineon stock jumps as German chipmaker delivers beat-and-raise Q1
Technologies (ETR:IFXGn) raised its full-year revenue outlook slightly on Tuesday, citing expected currency effects, after ...
Investing11h
5 Charts Indicating That Market's Bullish Trend Remains Intact
Nasdaq 100, S&P 500, iShares iBoxx $ High Yield Corporate Bond ETF, The Consumer Discretionary Select Sector SPDR® Fund. Read ...